QuickView for ICAM-3 receptor activity (biogroup)

1. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
2. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
3. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
4. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

There were no matches for ICAM-3 receptor activity

1. Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammati…
2. Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes
3. The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
4. The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
5. Thromboxane Receptor Antagonist to Improve Endothelial Cell Function